Abiomed (ABMD)

ABIOMED Holding Company, Inc. • ABIOMED Commercial, LLC • ABIOMED R&D, Inc. • Breethe, Inc. • Precardia, Inc • ABIOMED Australia Pte. Ltd • ABIOMED SARL • Precardia SAS • ABIOMED Europe, GmbH • AIS GmbH ...

IRS number

42743260

ABMD stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

15-12G

Securities registration termination

3 Jan 23

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

S-8 POS

Registration of securities for employees (post-effective amendment)

22 Dec 22

Transcripts

View all

ABMD

Earnings call transcript

2023 Q2

1 Nov 22

ABMD

Earnings call transcript

2023 Q1

4 Aug 22

ABMD

Earnings call transcript

2022 Q4

28 Apr 22

ABMD

Earnings call transcript

2022 Q3

4 Feb 22

ABMD

Earnings call transcript

2022 Q2

28 Oct 21

ABMD

Earnings call transcript

2022 Q1

5 Aug 21

ABMD

Earnings call transcript

2021 Q4

29 Apr 21

ABMD

Earnings call transcript

2021 Q3

28 Jan 21

ABMD

Earnings call transcript

2021 Q2

29 Oct 20

ABMD

Earnings call transcript

2021 Q1

6 Aug 20

Latest ownership filings

View all

MILLENNIUM MANAGEMENT LLC

Financial summary

Financial statements Chart ABMD financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Mar 22	Mar 21	Mar 20	Mar 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	182.34 mm	182.34 mm	182.34 mm	182.34 mm	182.34 mm	182.34 mm
Cash burn (monthly)	(no burn)	4.96 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	139.06 mm	n/a	n/a	n/a	n/a
Cash remaining	n/a	43.27 mm	n/a	n/a	n/a	n/a
Runway (months of cash)	n/a	8.7	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from Abiomed earnings reports.

Institutional ownership, Q3 2024

ABMD institutional ownership history Ownership history

7.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	4	9	-55.6%
Opened positions	2	1	+100.0%
Closed positions	7	460	-98.5%
Increased positions	0	2	EXIT
Reduced positions	0	3	EXIT

13F shares	Current	Prev Q	Change
Total value	443.40 mm	2.09 bn	-78.8%
Total shares	3.31 mm	3.31 mm	-0.2%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Capital VII FCPR Sofinnova	1.69 mm	$93.11 mm	0.0%
ABMD Abiomed	1.61 mm	$74.15 mm	0.0%
Ethic	712.00	$231.85 mm	NEW
Nemes Rush	136.00	$44.29 mm	NEW

Largest transactions	Shares	Bought/sold	Change
Sanctuary Advisors	0.00	-2.66 k	EXIT
Unique Wealth Strategies	0.00	-1.74 k	EXIT
IFP Advisors	0.00	-1.20 k	EXIT
Ethic	712.00	+712.00	NEW
BCS Barclays	0.00	-398.00	EXIT
Thrivent Trust Co of Tennessee	0.00	-185.00	EXIT
Nemes Rush	136.00	+136.00	NEW
Advisor	0.00	-40.00	EXIT
Mather	0.00	-14.00	EXIT
ABMD Abiomed	1.61 mm	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.